Vascular-targeted therapies in oncology /
| Other Authors: | |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Chichester, England ; Hoboken, NJ :
John Wiley & Sons,
[2006]
|
| Subjects: |
Table of Contents:
- Tumor vasculature : a target for anticancer therapies
- Abnormal microvasculature and defective microcirculatory function in solid tumors
- The role of microvasculature in metastasis formation
- Development of agents that selectively disrupt tumor vasculature : a historical perspective
- Morphologic manifestations of vascular-disrupting agents in preclinical models
- Molecular recognition of the colchicine binding site as a design paradigm for the discovery and development of vascular disrupting agents
- Combined modality approaches using vascular-disrupting agents
- Vascular-targeting therapies and hyperthermia
- Flavones and xanthenones as vascular-disrupting agents
- Targeting inside-out phospholipids on tumor blood vessels in pancreatic cancer
- Cadherin antagonists as vascular-targeting agents
- Alphastatin : a pluripotent inhibitor of activated endothelial cells
- Cationic lipid complexes to target tumor endothelium
- Development of vascular-targeting cancer gene therapy
- Vascular-disrupting strategies combined with bacterial spores targeting hypoxic regions of solid tumors
- Imaging the effects of vascular-targeting agents
- Clinical progress in tumor vasculature-disrupting therapies
- Use of vascular-disrupting agents in non-oncology indications